Skip to main content
Erschienen in: Endocrine 3/2020

02.03.2020 | Original Article

Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up

verfasst von: C. Giani, L. Torregrossa, P. Piaggi, A. Matrone, D. Viola, E. Molinaro, L. Agate, C. Romei, C. Ugolini, L. De Napoli, G. Materazzi, F. Basolo, R. Elisei

Erschienen in: Endocrine | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the epidemiological, clinical, and pathological features of follicular (FVPTC) and classical (CVPTC) variants of papillary thyroid cancer and to correlate their outcomes according to different features.

Methods

Retrospective analysis of FVPTC and CVPTC patients selected at the moment of surgical treatment from 1999 to 2004, with a median follow-up of 15 years.

Results

Several significant differences were found between FVPTC and CVPTC such as the mean age at diagnosis, the presence of tumor capsule, the presence of thyroid capsule invasion, the presence of perithyroid soft tissue invasion, the lymph node metastases, the multifocality and bilaterality. At the end of follow-up only 9% (77/879) patients were not cured. However, a statistically significant lower percentage of persistent disease was found in the FVPTC than in the CVPTC group (3% vs. 14.5%, respectively, p < 0.0001). In multivariate analysis, the absence of the tumor capsule (OR = 6.75) or its invasion (OR = 7.89), the tumor size ≥4 cm (OR = 4.29), the variant CVPTC (OR = 3.35), and the presence of lymph node metastases (OR = 3.16) were all independent risk factors for the persistence of the disease.

Conclusions

Despite an overall excellent prognosis of both variants, a higher percentage of CVPTC than FVPTC patients had a persistent disease. The absence of tumor capsule or its invasion, the tumor size ≥4 cm and the presence of lymph node metastases are other prognostic factors for the persistence of the disease. In contrast, the presence of an intact tumor capsule is the only good prognostic factor for their outcome.
Literatur
1.
Zurück zum Zitat G. Jossart, O. Clark, Well-differentiated thyroid cancer. Curr. Probl. Surg. 31, 933–1012 (1994)CrossRef G. Jossart, O. Clark, Well-differentiated thyroid cancer. Curr. Probl. Surg. 31, 933–1012 (1994)CrossRef
2.
Zurück zum Zitat A.K.Y. Lam, C.Y. Lo, K.S.L. Lam, Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr. Pathol. 16, 323–330 (2005)CrossRef A.K.Y. Lam, C.Y. Lo, K.S.L. Lam, Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr. Pathol. 16, 323–330 (2005)CrossRef
3.
Zurück zum Zitat M.L. Carcangiu, G. Zampi, A. Pupi, A. Castagnoli, J. Rosai, Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55, 805–828 (1985)CrossRef M.L. Carcangiu, G. Zampi, A. Pupi, A. Castagnoli, J. Rosai, Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55, 805–828 (1985)CrossRef
4.
Zurück zum Zitat S.O. Sebastian, J.M. Gonzalez, P.P. Paricio, J.S. Perez, D.P. Flores, A.P. Madrona, P.R. Romero, F.J. Tebar, Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch. Surg. 135, 272–277 (2000)CrossRef S.O. Sebastian, J.M. Gonzalez, P.P. Paricio, J.S. Perez, D.P. Flores, A.P. Madrona, P.R. Romero, F.J. Tebar, Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch. Surg. 135, 272–277 (2000)CrossRef
5.
Zurück zum Zitat X.-M. Yu, D.F. Schneider, G. Leverson, H. Chen, R.S. Sippel, Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid 23, 1263–1268 (2013)CrossRef X.-M. Yu, D.F. Schneider, G. Leverson, H. Chen, R.S. Sippel, Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid 23, 1263–1268 (2013)CrossRef
6.
Zurück zum Zitat E.T. Tielens, S.I. Sherman, R.H. Hruban, P.W. Ladenson, Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73, 424–431 (1994)CrossRef E.T. Tielens, S.I. Sherman, R.H. Hruban, P.W. Ladenson, Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73, 424–431 (1994)CrossRef
7.
Zurück zum Zitat V.A. Livolsi, Papillary thyroid carcinoma: an update. Mod Pathol 24, S1–S9 (2011) V.A. Livolsi, Papillary thyroid carcinoma: an update. Mod Pathol 24, S1–S9 (2011)
8.
Zurück zum Zitat G. Crile, J.B. Hazard, Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann. Surg. 138, 33–38 (1953)CrossRef G. Crile, J.B. Hazard, Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann. Surg. 138, 33–38 (1953)CrossRef
9.
Zurück zum Zitat M. Dailey, M. Soley, S. Lindsay, Carcinoma of the thyroid gland; a clinical and pathologic study. Am. J. Med 9, 194–199 (1950)CrossRef M. Dailey, M. Soley, S. Lindsay, Carcinoma of the thyroid gland; a clinical and pathologic study. Am. J. Med 9, 194–199 (1950)CrossRef
10.
Zurück zum Zitat L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295, 2164–2167 (2006)CrossRef L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295, 2164–2167 (2006)CrossRef
11.
Zurück zum Zitat A.Y. Chen, A. Jemal, E.M. Ward, Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115, 3801–3807 (2009)CrossRef A.Y. Chen, A. Jemal, E.M. Ward, Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115, 3801–3807 (2009)CrossRef
12.
Zurück zum Zitat H.Y. Chang, J. Der Lin, S.C. Chou, T.C. Chao, C. Hsueh, Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J. Clin. Oncol. 36, 688–693 (2006)CrossRef H.Y. Chang, J. Der Lin, S.C. Chou, T.C. Chao, C. Hsueh, Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J. Clin. Oncol. 36, 688–693 (2006)CrossRef
13.
Zurück zum Zitat Z.W. Baloch, V.A. Livolsi, Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod. Pathol. 13, 861–865 (2000)CrossRef Z.W. Baloch, V.A. Livolsi, Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod. Pathol. 13, 861–865 (2000)CrossRef
14.
Zurück zum Zitat P. Hagag, N. Hod, E. Kummer, M. Cohenpour, T. Horne, M. Weiss, Follicular variant of papillary thyroid carcinoma: clinical-pathological characterization and long-term follow-up. Cancer J. 12, 275–282 (2006)CrossRef P. Hagag, N. Hod, E. Kummer, M. Cohenpour, T. Horne, M. Weiss, Follicular variant of papillary thyroid carcinoma: clinical-pathological characterization and long-term follow-up. Cancer J. 12, 275–282 (2006)CrossRef
15.
Zurück zum Zitat B.H.H. Lang, C.Y. Lo, W.F. Chan, A.K.Y. Lam, K.Y. Wan, Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J. Surg. 30, 752–758 (2006)CrossRef B.H.H. Lang, C.Y. Lo, W.F. Chan, A.K.Y. Lam, K.Y. Wan, Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J. Surg. 30, 752–758 (2006)CrossRef
16.
Zurück zum Zitat J. Zidan, D. Karen, M. Stein, E. Rosenblatt, W. Basher, A. Kuten, Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 97, 1181–1185 (2003)CrossRef J. Zidan, D. Karen, M. Stein, E. Rosenblatt, W. Basher, A. Kuten, Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 97, 1181–1185 (2003)CrossRef
17.
Zurück zum Zitat C. Passler, G. Prager, C. Scheuba, B.E. Niederle, K. Kaserer, G. Zettinig, B. Niederle, Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch. Surg. 138, 1362–1366 (2003)CrossRef C. Passler, G. Prager, C. Scheuba, B.E. Niederle, K. Kaserer, G. Zettinig, B. Niederle, Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch. Surg. 138, 1362–1366 (2003)CrossRef
18.
Zurück zum Zitat A.R. Burningham, J. Krishnan, B.J. Davidson, M.D. Ringel, K.D. Burman, Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy. Otolaryngol. Head. Neck Surg. 132, 840–844 (2005)CrossRef A.R. Burningham, J. Krishnan, B.J. Davidson, M.D. Ringel, K.D. Burman, Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy. Otolaryngol. Head. Neck Surg. 132, 840–844 (2005)CrossRef
19.
Zurück zum Zitat X. Shi, R. Liu, F. Basolo, R. Giannini, X. Shen, D. Teng, H. Guan, Z. Shan, W. Teng, T.J. Musholt, K. Al-Kuraya, L. Fugazzola, C. Colombo, E. Kebebew, B. Jarzab, A. Czarniecka, B. Bendlova, V. Sykorova, M. Sobrinho-Simães, P. Soares, Y.K. Shong, T.Y. Kim, S. Cheng, S.L. Asa, D. Viola, R. Elisei, L. Yip, C. Mian, F. Vianello, Y. Wang, S. Zhao, G. Oler, J.M. Cerutti, E. Puxeddu, S. Qu, Q. Wei, H. Xu, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, A.K. Lam, G. Riesco-Eizaguirre, P. Santisteban, H. Yu, G. Tallini, E.H. Holt, V. Vasko, M. Xing, Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. J. Clin. Endocrinol. Metab. 101, 264–274 (2016)CrossRef X. Shi, R. Liu, F. Basolo, R. Giannini, X. Shen, D. Teng, H. Guan, Z. Shan, W. Teng, T.J. Musholt, K. Al-Kuraya, L. Fugazzola, C. Colombo, E. Kebebew, B. Jarzab, A. Czarniecka, B. Bendlova, V. Sykorova, M. Sobrinho-Simães, P. Soares, Y.K. Shong, T.Y. Kim, S. Cheng, S.L. Asa, D. Viola, R. Elisei, L. Yip, C. Mian, F. Vianello, Y. Wang, S. Zhao, G. Oler, J.M. Cerutti, E. Puxeddu, S. Qu, Q. Wei, H. Xu, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, A.K. Lam, G. Riesco-Eizaguirre, P. Santisteban, H. Yu, G. Tallini, E.H. Holt, V. Vasko, M. Xing, Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. J. Clin. Endocrinol. Metab. 101, 264–274 (2016)CrossRef
20.
Zurück zum Zitat Y.E. Nikiforov, R.R. Seethala, G. Tallini, Z.W. Baloch, F. Basolo, L.D.R. Thompson, J.A. Barletta, B.M. Wenig, GhuzlanA. Al, K. Kakudo, T.J. Giordano, V.A. Alves, E. Khanafshar, S.L. Asa, A.K. El-Naggar, W.E. Gooding, S.P. Hodak, R.V. Lloyd, G. Maytal, O. Mete, M.N. Nikiforova, V. Nosé, M. Papotti, D.N. Poller, P.M. Sadow, A.S. Tischler, T.R. Michael, K.B. Wall, V.A. LiVolsi, G.W. Randolph, R.A. Ghossein, Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2, 1023–1029 (2016)CrossRef Y.E. Nikiforov, R.R. Seethala, G. Tallini, Z.W. Baloch, F. Basolo, L.D.R. Thompson, J.A. Barletta, B.M. Wenig, GhuzlanA. Al, K. Kakudo, T.J. Giordano, V.A. Alves, E. Khanafshar, S.L. Asa, A.K. El-Naggar, W.E. Gooding, S.P. Hodak, R.V. Lloyd, G. Maytal, O. Mete, M.N. Nikiforova, V. Nosé, M. Papotti, D.N. Poller, P.M. Sadow, A.S. Tischler, T.R. Michael, K.B. Wall, V.A. LiVolsi, G.W. Randolph, R.A. Ghossein, Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2, 1023–1029 (2016)CrossRef
21.
Zurück zum Zitat Y.E. Nikiforov, Z.W. Baloch, S.P. Hodak, T.J. Giordano, R.V. Lloyd, R.R. Seethala, B.M. Wenig, Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features. JAMA Oncol 4, 1125–1126 (2018)CrossRef Y.E. Nikiforov, Z.W. Baloch, S.P. Hodak, T.J. Giordano, R.V. Lloyd, R.R. Seethala, B.M. Wenig, Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features. JAMA Oncol 4, 1125–1126 (2018)CrossRef
23.
Zurück zum Zitat B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRef B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRef
24.
Zurück zum Zitat F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W.A. Smit, W. Wiersinga, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)CrossRef F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W.A. Smit, W. Wiersinga, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)CrossRef
25.
Zurück zum Zitat R.A. DeLellis, R.V. Lloyd, P.U. Heitz. EC, editors. World Health Organization International Classification of Tumors. Pathology and Genetics of Tumors of Endocrine Organs. Lyon, France: IARC Press (2004) R.A. DeLellis, R.V. Lloyd, P.U. Heitz. EC, editors. World Health Organization International Classification of Tumors. Pathology and Genetics of Tumors of Endocrine Organs. Lyon, France: IARC Press (2004)
26.
Zurück zum Zitat F. Tunca, I.C. Sormaz, Y. Iscan, Y.G. Senyurek, T. Terzioglu, Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma. J. Endocrinol. Investig 38, 1327–1334 (2015)CrossRef F. Tunca, I.C. Sormaz, Y. Iscan, Y.G. Senyurek, T. Terzioglu, Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma. J. Endocrinol. Investig 38, 1327–1334 (2015)CrossRef
27.
Zurück zum Zitat R. Elisei, E. Molinaro, L. Agate, V. Bottici, L. Masserini, C. Ceccarelli, F. Lippi, L. Grasso, F. Basolo, G. Bevilacqua, P. Miccoli, G. Di Coscio, P. Vitti, F. Pacini, A. Pinchera, Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J. Clin. Endocrinol. Metab. 95, 1516–1527 (2010)CrossRef R. Elisei, E. Molinaro, L. Agate, V. Bottici, L. Masserini, C. Ceccarelli, F. Lippi, L. Grasso, F. Basolo, G. Bevilacqua, P. Miccoli, G. Di Coscio, P. Vitti, F. Pacini, A. Pinchera, Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J. Clin. Endocrinol. Metab. 95, 1516–1527 (2010)CrossRef
28.
Zurück zum Zitat R. Elisei, D. Viola, L. Torregrossa, R. Giannini, C. Romei, C. Ugolini, E. Molinaro, L. Agate, A. Biagini, C. Lupi, L. Valerio, G. Materazzi, P. Miccoli, P. Piaggi, A. Pinchera, P. Vitti, F. Basolo, The BRAFV600E mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J. Clin. Endocrinol. Metab. 97, 4390–4398 (2012)CrossRef R. Elisei, D. Viola, L. Torregrossa, R. Giannini, C. Romei, C. Ugolini, E. Molinaro, L. Agate, A. Biagini, C. Lupi, L. Valerio, G. Materazzi, P. Miccoli, P. Piaggi, A. Pinchera, P. Vitti, F. Basolo, The BRAFV600E mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J. Clin. Endocrinol. Metab. 97, 4390–4398 (2012)CrossRef
29.
Zurück zum Zitat F. Wang, X. Yu, X. Shen, G. Zhu, Y. Huang, R. Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A.K. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sýkorová, Y. Wang, S. Liu, J. Zhao, S. Zhao, M. Xing, The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer. J. Clin. Endocrinol. Metab. 102, 3241–3250 (2017)CrossRef F. Wang, X. Yu, X. Shen, G. Zhu, Y. Huang, R. Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A.K. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sýkorová, Y. Wang, S. Liu, J. Zhao, S. Zhao, M. Xing, The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer. J. Clin. Endocrinol. Metab. 102, 3241–3250 (2017)CrossRef
30.
Zurück zum Zitat G. Sapuppo, M. Tavarelli, A. Belfiore, R. Vigneri, G. Pellegriti, Time to separate persistent from recurrent differentiated thyroid cancer: different conditions with different outcomes. J. Clin. Endocrinol. Metab. 104, 258–265 (2018)CrossRef G. Sapuppo, M. Tavarelli, A. Belfiore, R. Vigneri, G. Pellegriti, Time to separate persistent from recurrent differentiated thyroid cancer: different conditions with different outcomes. J. Clin. Endocrinol. Metab. 104, 258–265 (2018)CrossRef
Metadaten
Titel
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up
verfasst von
C. Giani
L. Torregrossa
P. Piaggi
A. Matrone
D. Viola
E. Molinaro
L. Agate
C. Romei
C. Ugolini
L. De Napoli
G. Materazzi
F. Basolo
R. Elisei
Publikationsdatum
02.03.2020
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02229-0

Weitere Artikel der Ausgabe 3/2020

Endocrine 3/2020 Zur Ausgabe

Endocrine imaging

Pemberton sign

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.